Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06506695

Optimizing Surgical and Prosthetic Workflow for Implant-supported Ear and Nose Prostheses With Early Loading and Distant Prosthesis Fabrication: A Prospective Cohort Study

Facial defects created by trauma, oncological procedures or congenital conditions can be repaired with ear, nose and/or eye prostheses. These are fixed on intraosseous implants placed in the temporal, nasal and orbital bone. To date, an osseointegration period of 3-6 months is maintained after which the implants are loaded.

This study aims to achieve two goals:

1. To load the implants with a nose or ear prosthesis within one month (preferably <3 weeks). Patients with an orbital prosthesis will not be recruited. In other words, an optimization of an existing protocol will be investigated. The quality of life of the patients as well as possible complications of the implants will be investigated. 2. Because of the short time between the surgery and the placement of the prosthesis, the prosthesis will be fabricated remotely. This means that the patient will not have to travel to the prosthetist. The feasibility and aesthetics will be analyzed through questionnaires for the patient.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients with a facial defect in the nasal and/or temporal area that will not be repaired with autologous tissue;
  • Adult patients receiving oncological resection or trauma resulting in a facial defect in the nose and/or ear that will not be repaired with autologous tissue;
  • Patients who can come to the hospital every week for 6 weeks.

Exclusion criteria

  • Patients with insufficient bone mass for implant placement
  • Patients who cannot come to the hospital for weekly follow-ups
  • Patients that wish an autologous reconstruction
  • Patient is unable to tolerate general anesthesia

Treatment and study plan

Craniofacial implant placement

Device
  • Resection of oncologic process or remnants after trauma if necessary
  • Placement of craniofacial implants in the nasal floor and/or the temporal bone.
  • Placement of split thickness skin graft around the implants
  • Placement of nose and/or ear prosthesis within 3 weeks

Primary outcomes

  1. Rate of implant survival in nasal and temporal bone from 0-100%

    Time frame: 6 months after placement of implants

    Investigate craniofacial implant survival. 100% being better than 0%.

  2. Peri-implant complications using the Holgers' (grade 0-4)

    Time frame: 6 months after placement of implants

    Investigate craniofacial peri-implant complications after early loading concept using the Holgers' scale from 0, meaning excellent peri-implant status to 4 necessitating removal of the implant.

  3. Peri-implant complications using the IPS scale (IPS-score)

    Time frame: 6 months after placement of implants

    Investigate craniofacial peri-implant complications after early loading concept using the IPS scale. Only the 'percutaneous' part of the scale will be used. IPS scale ranges from no treatment to removal of the implant.

  4. Quality of Life with SF-36, SWLS and RSES and self-made questionnaire

    Time frame: Before treatment and 6 months after implant placement

    Assessing the patient's quality of life using the early loading protocol with standardised and self-made questionnaires. The SF-36 scoring will result in 8 scales ranging from 0-100 with the lower the score the more disability. SWLS will result in a range of 5-35. The higher the score the higher the satisfaction with life. RSES ranges from 0-30. Scores between 15 and 25 are considered in the normal range whereas scores below 15 suggest low self-esteem. The self-made questionnaires will result in percentages of the given answers.

Secondary outcomes

  1. Difference in surface matching of the midface and temporal area in mm

    Time frame: 6 months after implant placement

    By matching and comparing surface scans we can analyse the swelling in the midface and temporal area after directly after surgery and postoperatively. These will result in positive or negative changes and expressed in millimeters.

  2. Implant stability over time with implant stability quotient (ISQ) range 1-100

    Time frame: 6 months after implant placement

    By measuring stability we can create an osseointegration timeline for craniofacial implants. Higher values indicate higher stability. Values in between 55 and 85 are considered acceptable.

  3. Feasibility of remote prosthesis fabrication

    Time frame: 6 months after implant placement

    Questionnaires assessing the experience of the patient and aesthetics of the prosthesis

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 17, 2024
Registry last updated
Jul 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.